Accelerating Evidence-Informed Vaccine Introductions: Lessons from the Hexavalent Early Adopters Workshop
Vaccines · 19.05.2026 · 14 (5) · 452
DOI: 10.3390/vaccines14050452 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vaccines, online erschienen am 19.05.2026. Verfasst von Kathryn L Hopkins und 29 weiteren Autor:innen. Beteiligte Einrichtung: Sabin Vaccine Institute, Washington, DC 20006, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization, Gavi, Gavi, the Vaccine Alliance.
Abstract (Originalsprache)
Background/Objectives: Transitions to new vaccines or antigen schedules represent complex system changes requiring coordinated governance, reliable data systems, domestic financing, and multisectoral collaboration. In 2025, African countries were moving toward a switch from separate pentavalent and inactivated poliovirus vaccines to the combined hexavalent vaccine. This project report describes the Hexavalent Vaccine Switch Early Adopters Workshop in Dakar, Senegal, which included ten African countries, and its implications for future vaccine introductions.
Methods
We conducted a practice analysis drawing on structured documentation of plenary presentations, country case studies, interactive problem-solving sessions, and national roadmap exercises. A thematic framework aligned to ten process points for the hexa switch guided synthesis.
Results
Countries reported shared system vulnerabilities, including coexistence risks of legacy and new vaccine stocks, inconsistent data completeness, under-resourced vaccine safety surveillance, and financing uncertainties. Early adopter countries demonstrated operational feasibility, logistical efficiencies, and opportunities for reducing injection burden. Outputs included a Health System Adaptation Checklist, a Switch Risk Mitigation Catalog, and 12-month national roadmaps.
Conclusions
Regional peer-learning mechanisms can accelerate decision-making, improve operational quality, and strengthen accountability for vaccine introductions. Structured cross-country collaborations can transform a product switch into a scalable system-strengthening opportunity.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Sabin Vaccine Institute, Washington, DC 20006, USA.
- World Health Organization Regional Office for Africa (WHO AFRO), Brazzaville, Congo.
- GCEI Secretariat/National Immunization Technical Advisory Group (NITAG), Nouakchott, Mauritania.
- Vaccines and Immunization Division, Ministry of Health, Kampala P.O Box 7272, Uganda.
- Immunization Division, Ministry of Health and Public Hygiene, Dakar 10000, Senegal.
- Regional Health Directorate, Trarza, Mauritania.
ORCID-Profile: Sidy Ndiaye, Ousseynou Badiane, Stephen C Hadler, Benjamin M Kagina, Elisabeth Wilhelm, Ronald Wasswa
Förderung
- World Health Organization
- Gavi
- Gavi, the Vaccine Alliance
Zitieren
APA
Hopkins, K. L., Ndiaye, S., Sidi Abdullah, Z., Atugonza, R., Badiane, O., Ba, K., Best, T., Bizimana, J. C., Cheikh, D., Andrianirinarison, J. C., Rwagitare, E., Essoh, T. A., Gonah, N., Hadler, S. C., Kagina, B. M., Lambou, L., Mangane, A., Kabweru, W. M., Sebatunzi, O. R., …, & Kabore, L. (2026). Accelerating Evidence-Informed Vaccine Introductions: Lessons from the Hexavalent Early Adopters Workshop. Vaccines, 14(5), 452. https://doi.org/10.3390/vaccines14050452
Vancouver
Hopkins KL, Ndiaye S, Sidi Abdullah Z, Atugonza R, Badiane O, Ba K, et al. Accelerating Evidence-Informed Vaccine Introductions: Lessons from the Hexavalent Early Adopters Workshop. Vaccines. 2026;14(5):452. doi:10.3390/vaccines14050452
BibTeX
@article{Hopkins2026,
author = {Hopkins, Kathryn L and Ndiaye, Sidy and Sidi Abdullah, Zeinebou and Atugonza, Rita and Badiane, Ousseynou and Ba, Khassoum and Best, Tyler and Bizimana, Jean Claude and Cheikh, Dah and Andrianirinarison, Jean Claude and Rwagitare, Eraste and Essoh, Tene-Alima and Gonah, Nhamo and Hadler, Stephen C and Kagina, Benjamin M and Lambou, Leopold and Mangane, Abdoulaye and Kabweru, Wilberforce Musoga and Sebatunzi, Osée Rurambya and Itawel Oumrou, Mohamedhen and Volazandry, Priscylla and Ramanandraibe, Lalao Harisoa and Ravelomanana, Noeline and Sommers, Theresa and Torre, Lisandro and Wilhelm, Elisabeth and Yawo, Atakouma D and Yokouide, Allarangar and Wasswa, Ronald and Kabore, Lassane},
title = {Accelerating Evidence-Informed Vaccine Introductions: Lessons from the Hexavalent Early Adopters Workshop},
journal = {Vaccines},
year = {2026},
volume = {14},
number = {5},
pages = {452},
doi = {10.3390/vaccines14050452}
}
EUVIMED